TRUMERIT – Trademark Portfolio
Entity Type: 54
TRUMERIT holds 29 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 19 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 28 trademarks are registered and 1 is pending. Notable registered marks include CES, ICD, ECAS, EDAS, and ICHP. The owner is based in PHILADELPHIA, PA.
3600 MARKET STREET
SUITE 400
PHILADELPHIA, PA 19104-2651
Showing of trademarks Trademarks
Trademark Classifications
TRUMERIT's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does TRUMERIT have?
TRUMERIT has 29 U.S. trademarks filed with the USPTO. Of these, 28 registered, 1 pending.
What trademark classes does TRUMERIT file in?
TRUMERIT files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.
What are TRUMERIT's most well-known trademarks?
TRUMERIT's registered trademark portfolio includes well-known marks such as CES, ICD, ECAS, EDAS, and ICHP. These are among 28 currently registered trademarks in the portfolio.
What is TRUMERIT's trademark registration success rate?
TRUMERIT has a 100% trademark registration rate, with 28 out of 28 resolved applications resulting in successful registration. Currently, 1 application is pending review.